Target intelligence / Profile preview

Novel transcript, antisense to cadherin-12 (ENSG00000286961)

Target
ENSG00000286961
Molecular classification
Other (Long non-coding RNA)
01

Overview

Novel transcript, antisense to cadherin-12" (ENSG00000286961) is a long non-coding RNA (lncRNA) identified as being transcribed from the DNA strand opposite to the **CDH12** (cadherin-12) gene[1]. Antisense lncRNAs are known to influence expression and regulation of their corresponding sense genes through several mechanisms, including chromatin modification, transcriptional interference, and RNA-mediated regulation[2][3]. While the precise functional role of this particular transcript is not characterized in current databases, studies on antisense transcripts in general indicate they can modulate the rates of production, processing, and stability of their sense transcripts by altering chromatin state, such as increasing histone acetylation and buffering the activity of chromatin-modifying complexes[2][3]. There is no evidence that this particular antisense transcript encodes a protein, acts as a therapeutic target, or is involved directly in human disease; rather, it is categorized as a regulatory non-coding RNA, whose biological effects (if characterized) would likely include epigenetic and transcriptional regulation at the CDH12 locus[1][2][3].

Other names
Novel transcript, antisense to CDH12ENSG00000286961CDH12-AS
02

Biological functions

Epigenetic regulationModulation of sense transcript dynamics (inferred from general roles of antisense lncRNAs)
03

Disease associations

Other (potential regulatory RNA; no direct disease role described)

Beyond the preview

Go deeper on Novel transcript, antisense to cadherin-12 (ENSG00000286961).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to cadherin-12 (ENSG00000286961).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call